Furthermore, the paradoxical effects of CaMKII isoforms have been described, as inhibition of CaMKII activity can be beneficial in stroke, and CaMKII inhibitors have been proposed as therapeutics promoting neuroprotection in cerebrovascular disease (Deng et al., 2017; Zhang et al., 2021). This evidence concerns the gene CAMK2G and stroke disorder.